Yoko Abe

Title: Yoko Abe: Innovator in Percutaneous Drug Absorption

Introduction

Yoko Abe is a prominent inventor based in Ibaraki, Japan. She has made significant contributions to the field of drug administration, particularly in enhancing percutaneous drug absorption. With a total of 2 patents, her work has the potential to improve the efficacy of drug delivery systems.

Latest Patents

Yoko Abe's latest patents include a method of promoting percutaneous drug absorption using 2-pyrrolidin-2-one. This innovative composition is designed for percutaneous drug administration and contains a compound where R₁ is a hydrogen atom or an alkyl group, and R₂ is a residue of aliphatic hydrocarbon. The composition effectively promotes percutaneous drug absorption. Another notable patent is a composition for percutaneous administration that contains a nicotinic ester or an isonicotinic ester, where R and R' each represent an alkyl group with five or more carbon atoms. This composition also enhances the percutaneous absorption of active ingredients.

Career Highlights

Throughout her career, Yoko Abe has worked with notable companies such as Nitto-Denko Corporation and Nitto Electric Industrial Co., Ltd. Her experience in these organizations has contributed to her expertise in drug delivery systems and innovation in pharmaceutical technology.

Collaborations

Yoko Abe has collaborated with esteemed colleagues, including Susumu Satoh and Yoshiaki Itoh. These partnerships have fostered a collaborative environment that encourages innovation and the development of new technologies in drug administration.

Conclusion

Yoko Abe's contributions to the field of percutaneous drug absorption highlight her role as a leading inventor. Her innovative patents and collaborations reflect her commitment to advancing pharmaceutical technology.